Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:40 PM
Ignite Modification Date:
2025-12-24 @ 4:40 PM
NCT ID:
NCT00471666
Eligibility Criteria:
* INCLUSION CRITERIA (Screening):
Age 1 - 20 years
Male or non-pregnant female
Resident of Tien gu bougou or Bougoudiana
EXCLUSION CRITERIA (Screening):
History or clinical evidence of severe and/or chronic illness
History of allergy to artesunate, amodiaquine, albendazole, praziquantel or mebendazole
Plans to relocate outside the immediate vicinity of the village during the study period
INCLUSION CRITERIA (Matched prospective study):
Age 1 - 20 years
Male or non-pregnant female
Resident of Tien gu bougou or Bougoudiana
EXCLUSION CRITERIA (Matched prospective study):
History or clinical evidence of severe and/or chronic illness
History of allergy to artesunate, amodiaquine, albendazole, praziquantel or mebendazole
Plans to relocate outside the immediate vicinity of the village during the study period
Hemoglobin less than or equal to 8 g/dL
Symptoms of malaria with parasitemia greater than or equal to 100,000/microliters at enrollment
Recent history or clinical evidence of prostration, bleeding, respiratory distress, seizures, coma or obtundation, jaundice, inability to drink, persistent vomiting
INCLUSION CRITERIA: (Immunologic Extension Study)
Age \> 10 years
Male or non-pregnant female (by history)
Resident of Tien gu bougou or Bougoudiana
Willingness to allow storage of specimens for future research
EXCLUSION CRITERIA: (Immunologic Extension Study)
History or clinical evidence of severe and/or chronic illness
Hemoglobin less than or equal to g/dL
Positive pregnancy test
Clinical malaria (symptoms of malaria plus any malaria parasites identified on thick smear)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
1 Year
Maximum Age:
20 Years
Study:
NCT00471666
Study Brief:
Protocol Section:
NCT00471666